Case report: Deep molecular remissions post two separate CD19-targeted chimeric antigen receptor T-cell therapies do not prevent disease from relapsing in Philadelphia chromosome-positive acute…

Overview of attention for article published in Frontiers in oncology, November 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,675 followers.

RT @FrontOncology: New research: Case report: Deep molecular remissions post two separate CD19-targeted chimeric antigen receptor T-cell th…

05 Nov 2023

Reply Repost Favourite

New research: Case report: Deep molecular remissions post two separate CD19-targeted chimeric antigen receptor T-cell therapies do not prevent disease from relapsing in Philadelphia chromosome-positive acute lymphoblastic leukemia: Philadelphia… https://t.

05 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.